Hofseth Financial Statements From 2010 to 2025
| HBC Stock | NOK 2.30 0.03 1.32% |
Check Hofseth Biocare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hofseth Biocare's main balance sheet or income statement drivers, such as , as well as many indicators such as . Hofseth financial statements analysis is a perfect complement when working with Hofseth Biocare Valuation or Volatility modules.
Hofseth |
Hofseth Biocare ASA Company Profit Margin Analysis
Hofseth Biocare's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Hofseth Biocare Profit Margin | (1.14) % |
Most of Hofseth Biocare's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hofseth Biocare ASA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Hofseth Biocare ASA has a Profit Margin of -1.1385%. This is 89.84% lower than that of the Healthcare sector and 95.06% lower than that of the Biotechnology industry. The profit margin for all Norway stocks is 10.35% lower than that of the firm.
Hofseth Biocare ASA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Hofseth Biocare's current stock value. Our valuation model uses many indicators to compare Hofseth Biocare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hofseth Biocare competition to find correlations between indicators driving Hofseth Biocare's intrinsic value. More Info.Hofseth Biocare ASA is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hofseth Biocare's earnings, one of the primary drivers of an investment's value.About Hofseth Biocare Financial Statements
Hofseth Biocare investors utilize fundamental indicators, such as revenue or net income, to predict how Hofseth Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Hofseth BioCare ASA, a biotech company, offers value added biomarine ingredients and finished products for human consumption and pet in Norway. The company was founded in 2000 and is headquartered in lesund, Norway. HOFSETH BIOCARE operates under Pharmaceuticals And Biosciences classification in Norway and is traded on Oslo Stock Exchange. It employs 44 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Hofseth Stock
Hofseth Biocare financial ratios help investors to determine whether Hofseth Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hofseth with respect to the benefits of owning Hofseth Biocare security.